Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Shaun McMeans; Timothy Holtzer; Sam Rua; David Martyr; Thomas Bachmann; Gerard Vaillant

Premium

HTG Molecular has made several new appointments to its executive team. Shaun McMeans has been named vice president of finance, administration, and chief technology officer; Timothy Holtzer has been named vice president of clinical diagnostic development; and Sam Rua has been named vice president of regulatory affairs and quality systems.

McMeans previously was CEO of Securaplane Technologies. Holtzer held various positions related to diagnostics at DiagnoCure, Centocor, and Abbott Laboratories. Rua was formerly vice president of global regulatory and clinical affairs at Beckman Coulter.


David Martyr has been named CEO of Tecan. The Swiss tools vendor said that Martyr will join the firm no later than Oct. 8, 2012, after he fulfills his contractual obligations to Danaher, where he is group executive and vice president. He previously was president of Leica Microsystems until Danaher acquired that firm in 2009.

Martyr succeeds Thomas Bachmann, who had held the position since 2005 and has left the firm. Board member Gerard Vaillant will serve as acting CEO until Martyr is ready to run the firm.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.